Pat Brady

Prior to joining GrowthWorks Capital in 1998, Pat Brady worked six years at Inex Pharmaceuticals (now Tekmira Pharmaceuticals) and DynaMotive Technologies Corp. in financial and corporate development capacities.

Pat serves as a Board director or observer for Celator Technologies, Inimex Pharmaceuticals Inc., MSI Methylation Sciences Inc., Neuromed Pharmaceuticals, OncoGenex Technologies, and Xenon Genetics.

Pat holds an MBA from the University of Western Ontario and was a former professional athlete. He is a past director of the BC Biotech Association.